Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;14(4):578-86.
doi: 10.1177/1359105309103577.

Autonomous regulation and locus of control as predictors of antiretroviral medication adherence

Ian Lynam  1 , Delwyn Catley, Kathy Goggin, Joshua L Rabinowitz, Mary M Gerkovich, Karen Williams, Julie Wright; MOTIV8
Collaborators, Affiliations

Autonomous regulation and locus of control as predictors of antiretroviral medication adherence

Ian Lynam et al. J Health Psychol. 2009 May.

Abstract

The purpose of the current study was to examine the interrelationships between autonomous regulation (AR) and locus of control (LOC) and their prediction of Antiretroviral Therapy (ART) adherence among 189 HIV+ patients. Path analyses revealed that neither AR nor LOC directly predicted adherence although AR was indirectly related when mediated by self-efficacy. AR was positively related to internal and doctors LOC, but not related to chance or others LOC. Overall, results support Self-determination Theory's conceptualization of AR and indicate that AR may be a more robust predictor of medication adherence than LOC variables.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Initial path analysis model predicting adherence *p<.01.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aardex. Medication Event Monitoring System. Union City, CA: 2006.
    1. Alfonso V, Geller J, Bermbach N, Drummond A, Montaner JS. Becoming a “treatment success”: what helps and what hinders patients from achieving and sustaining undetectable viral loads. AIDS Patient Care and STDs. 2006;20(5):326–334. - PubMed
    1. Altice FL, Friedland GH. The era of adherence to HIV therapy. Annals of Internal Medicine. 1998;129(6):503–505. - PubMed
    1. Bane C, Hughes CM, McElnay JC. The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Education and Counseling. 2006;60(2):187–193. - PubMed
    1. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clinical Infectious Disease. 2000;30(Suppl 2):S171–176. - PubMed

Publication types

Substances